January 07, 2025 05:08 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Delhi assembly elections on Feb 5, results on Feb 8 | Allu Arjun visits boy injured during Pushpa 2 stampede in Hyderabad | Donald Trump repeats his US-Canada merger offer after Justin Trudeau's resignation | India's HMPV cases surge to 7 after two cases reported from Nagpur | H-1B visa renewal will get simpler in 2025, Indians to benefit most as home country travel won't be required | As India detects 3 HMPV cases, #lockdown trends; Centre says no need to panic | Justin Trudeau announces resignation as Canada's PM amid rising pressure by partymates | 8 jawans, driver killed as Maoists blow up security vehicle in Chhattisgarh's Bijapur | Atul Subhash suicide: Karnataka High Court refuses to quash FIR against wife Nikita Singhania | Delhi elections: Congress launches Pyari Didi scheme promising Rs. 2,500 per month to women residents
Glenmark launches Tavulus for COPD treatment in Spain

Glenmark launches Tavulus for COPD treatment in Spain

Oct 11, 2021, at 07:18 pm

Mumbai/UNI: Pharma major Glenmark Pharma Monday announced the launch of a bioequivalent version of Tiotropium Bromide dry powder inhaler (DPI) under the brand name Tavulus in Spain for the treatment of chronic obstructive pulmonary disease (COPD).

Latest Headlines
Glenmark launches Tavulus for COPD treatment in Spain Mon, Oct 11 2021